| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Josefin Dahlbom, Tobias Backström, Katrin Lundstedt-Enkel, Svante Winber. Aggression and monoamines: effects of sex and social rank in zebrafish (Danio rerio). Behavioural brain research. vol 228. issue 2. 2012-05-23. PMID:22192379. |
in addition, effects on the brain serotonergic and dopaminergic neurotransmitter systems after agonistic interaction are well studied in many species, but not in zebrafish. |
2012-05-23 |
2023-08-12 |
zebrafish |
| b' Ljiljana Jaukovi\\xc4\\x87, Tihomir V Ili\\xc4\\x87, Marija Dopudja, Boris Ajdinovi\\xc4\\x8. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results. Vojnosanitetski pregled. vol 69. issue 2. 2012-05-15. PMID:22500370.' |
123i-fp-cit brain single-photon emission computed tomography (spect), datscan imaging, offers a possibility to study structural and biochemical integrity of presinaptic dopaminergic neurotransmitter system. |
2012-05-15 |
2023-08-12 |
Not clear |
| E P Rico, D B Rosemberg, K J Seibt, K M Capiotti, R S Da Silva, C D Bona. Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicology and teratology. vol 33. issue 6. 2012-05-14. PMID:21907791. |
here, we present a review regarding the role of different excitatory and inhibitory neurotransmitter systems in zebrafish, such as dopaminergic, serotoninergic, cholinergic, purinergic, histaminergic, nitrergic, glutamatergic, glycinergic, and gabaergic systems, and emphasizing their features as pharmacological and toxicological targets. |
2012-05-14 |
2023-08-12 |
zebrafish |
| Rajesh S Yadav, Lalit P Chandravanshi, Rajendra K Shukla, Madhu L Sankhwar, Reyaz W Ansari, Pradeep K Shukla, Aditya B Pant, Vinay K Khann. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. Neurotoxicology. vol 32. issue 6. 2012-05-02. PMID:21839772. |
our recent studies have shown that curcumin protects arsenic induced neurotoxicity by modulating oxidative stress, neurotransmitter levels and dopaminergic system in rats. |
2012-05-02 |
2023-08-12 |
rat |
| Lydia M Mexas, Virginia R Florang, Jonathan A Door. Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite. Neurotoxicology. vol 32. issue 4. 2012-04-23. PMID:21514317. |
parkinson's disease (pd) is a neurodegenerative disorder marked by the selective loss of dopaminergic neurons, leading to a decrease of the neurotransmitter dopamine (da). |
2012-04-23 |
2023-08-12 |
Not clear |
| Laura Hondebrink, Jan Meulenbelt, Marieke Meijer, Martin van den Berg, Remco H S Westerin. High concentrations of MDMA ('ecstasy') and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells. Neuropharmacology. vol 61. issue 1-2. 2012-04-17. PMID:21497613. |
our data suggest that the dat-independent increase in extracellular da in vivo is not due to direct stimulation of exocytosis, but rather to effects of these drugs on other neurotransmitter systems that innervate the dopaminergic system. |
2012-04-17 |
2023-08-12 |
Not clear |
| Jussi Hirvonen, Jarmo Hietala, Jaana Kajander, Juha Markkula, Helena Rasi-Hakala, Jouko K Salminen, Kjell Någren, Sargo Aalto, Hasse Karlsso. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET. Journal of psychopharmacology (Oxford, England). vol 25. issue 10. 2012-04-06. PMID:20829308. |
antidepressant drug treatment and psychotherapy are both effective in treating major depression, but there are no published studies comparing the effects of these two treatments on the dopaminergic neurotransmitter system in major depression. |
2012-04-06 |
2023-08-12 |
Not clear |
| R Maldonado, F Berrendero, A Ozaita, P Robled. Neurochemical basis of cannabis addiction. Neuroscience. vol 181. 2012-03-16. PMID:21334423. |
several neurotransmitter systems involved in the addictive effects of other prototypical drugs of abuse, such as the dopaminergic and the opioid system are also involved in cannabis addiction. |
2012-03-16 |
2023-08-12 |
Not clear |
| Agnieszka Permoda-Osip, Janusz Rybakowsk. [Glutamatergic conception of mood disorders]. Psychiatria polska. vol 45. issue 6. 2012-03-06. PMID:22335130. |
the neurotransmitter theories of the pathogenesis and treatment of mood disorders presented so far focused mainly on serotonergic and catecholaminergic (noradrenergic and dopaminergic) transmission. |
2012-03-06 |
2023-08-12 |
Not clear |
| Daniel Collerton, Elaine Perr. Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies. Consciousness and cognition. vol 20. issue 4. 2012-02-24. PMID:21531149. |
variations in cholinergic, dopaminergic and serotonergic neurotransmitter function during sleep and during hallucinations in lewy body dementias, together with relevant drug effects suggest that, on the whole, different, potentially opposite, changes characterise the two states. |
2012-02-24 |
2023-08-12 |
Not clear |
| Maria Trinidad Herrero, Javier Pagonabarraga, Gurutz Linazasor. Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. The neurologist. vol 17. issue 6 Suppl 1. 2012-02-21. PMID:22045327. |
parkinson disease is a progressive neurodegenerative disease that affects, among other neurotransmitter systems, the nigrostriatal dopaminergic projection. |
2012-02-21 |
2023-08-12 |
Not clear |
| Nicole A Datson, Niels Speksnijder, Inge E M de Jong, Peter J Steenbergen, Kenneth Vielsted Christensen, Krzysztof Potempa, Jan Torleif Pedersen, Jan Egebjerg, Pekka Kallunki, Erik B Nielsen, E Ronald de Kloet, Michael Didrikse. Hippocampal CA1 region shows differential regulation of gene expression in mice displaying extremes in behavioral sensitization to amphetamine: relevance for psychosis susceptibility? Psychopharmacology. vol 217. issue 4. 2012-02-13. PMID:21537941. |
psychosis susceptibility is mediated in part by the dopaminergic neurotransmitter system. |
2012-02-13 |
2023-08-12 |
mouse |
| Katharina M Iwaniuk, Jessica Schira, Sandra Weinhold, Marc Jung, James Adjaye, Hans Werner Müller, Peter Wernet, Hans-Ingo Trompete. Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood. Stem cells and development. vol 20. issue 8. 2012-01-27. PMID:21067317. |
they show differentiation into neuronal cells of a dopaminergic phenotype, which express neuronal markers such as synaptophysin, neuronal-specific nuclear protein, and neurofilament and release the neurotransmitter dopamine accompanied by expression of dopaminergic key factors tyrosine hydroxylase and nurr1 (nr4a2). |
2012-01-27 |
2023-08-12 |
human |
| Noriaki Koshikawa, Satoshi Fujita, Kazunori Adach. Behavioral pharmacology of orofacial movement disorders. International review of neurobiology. vol 97. 2011-10-25. PMID:21708305. |
regarding neurotransmitter systems, dopaminergic, cholinergic, γ-aminobutyric acid (gaba)ergic and glutamaterigic systems have been shown to be involved in rat rhythmical jaw movements. |
2011-10-25 |
2023-08-12 |
rat |
| E A Aristakesia. [Effect of apomorphine on the wakefulness--sleep cycle of the common frog Rana temporaria]. Zhurnal evoliutsionnoi biokhimii i fiziologii. vol 47. issue 4. 2011-10-14. PMID:21938912. |
comparative analysis of changes in wsc of amphibians and mammals in response to administration of dopamine and its agonists allows thinking that the role of the dopaminergic neurotransmitter system in regulation of the vertebrate wsc is unanimous: the low level of activity of this system facilitates development of sleep (catalepsy), whereas the high level provides reaction of arousal and is actively included in the system providing stress-reaction. |
2011-10-14 |
2023-08-12 |
Not clear |
| Iñaki-Carril Mundiñano, Maria-Cristina Caballero, Cristina Ordóñez, Maria Hernandez, Carla DiCaudo, Irene Marcilla, Maria-Elena Erro, Maria-Teresa Tuñon, Maria-Rosario Luqui. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta neuropathologica. vol 122. issue 1. 2011-10-13. PMID:21553300. |
the increased dopaminergic tone created in the obs of these patients could reflect a compensatory mechanism created by the early degeneration of other neurotransmitter systems and might contribute to the olfactory dysfunction exhibited by patients with neurodegenerative disorders. |
2011-10-13 |
2023-08-12 |
human |
| Annachiara Cagnin, Sara Pompanin, Valeria Manfioli, Chiara Briani, Alberto Zambon, Marina Saladini, Mauro Da. γ-Hydroxybutyric acid-induced psychosis and seizures. Epilepsy & behavior : E&B. vol 21. issue 2. 2011-10-11. PMID:21530412. |
we outline the deregulation of the neurotransmitter systems (gabaergic and dopaminergic networks) that are involved in these drug-drug interactions and that might be responsible for both psychosis and generalized tonic-clonic seizures resistant to standard treatments. |
2011-10-11 |
2023-08-12 |
Not clear |
| G A Oganesian, I V Romanova, E A Aristakesia. [Participation of vertebrate forebrain activating systems in organization of the wakefulness--sleep cycle]. Zhurnal evoliutsionnoi biokhimii i fiziologii. vol 47. issue 3. 2011-09-20. PMID:21780638. |
in such interactions a special role is played by the dopaminergic systems that perform neurosecretory function at the level of diencephalon and neurotransmitter function at the level of telencephalon. |
2011-09-20 |
2023-08-12 |
Not clear |
| G A Oganesian, I V Romanova, E A Aristakesia. [Participation of vertebrate forebrain activating systems in organization of the wakefulness--sleep cycle]. Zhurnal evoliutsionnoi biokhimii i fiziologii. vol 47. issue 3. 2011-09-20. PMID:21780638. |
concepts of a. i. karamyan and a. l. polenov about the stage pattern of development of cns and neurosecretory systems are presented as well as the interconnection of dopaminergic and glutamatergic neurotransmitter system in the mammalian neostriatum in the wakefulness-sleep cycle is considered. |
2011-09-20 |
2023-08-12 |
Not clear |
| Nicolaas I Bohnen, Roger L Albi. The cholinergic system and Parkinson disease. Behavioural brain research. vol 221. issue 2. 2011-09-09. PMID:20060022. |
non-motor comorbidities, such as cognitive impairment, are likely the result of an intricate interplay of multi-system degenerations and neurotransmitter deficiencies extending beyond the loss of dopaminergic nigral neurons. |
2011-09-09 |
2023-08-12 |
Not clear |